Drug
Arformoterol
Arformoterol is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_3
3
60%
Ph phase_2
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
3(60.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (20.0%)
Phase 33 (60.0%)
N/A1 (20.0%)
Trials by Status
withdrawn120%
completed480%
Recent Activity
0 active trials
Showing 5 of 5
withdrawnphase_3
Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)
NCT00662779
completedphase_3
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
NCT00909779
completednot_applicable
Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease
NCT01391559
completedphase_3
To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD
NCT00064415
completedphase_2
A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
NCT00583947
Clinical Trials (5)
Showing 5 of 5 trials
NCT00662779Phase 3
Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)
NCT00909779Phase 3
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
NCT01391559Not Applicable
Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease
NCT00064415Phase 3
To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD
NCT00583947Phase 2
A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5